“…Cdk1/cyclin B1 activity shields human cells against extrinsic death stimuli (Matthess et al, 2010). Cdk2 activation is mainly detected in apoptotic cells that exhibit G 1 /S phase arrest, as observed in ultraviolet irradiation-treated mesangial cells (Hiromura et al, 2002), etoposide-induced human leukemic cells (Choi et al, 2007;Bastin-Coyette et al, 2011), growth factor-deprived HUVEC cells (Levkau et al, 1998), G-Rh2-induced human hepatoma cells (Jin et al, 2000), panaxadiol-induced SK-HEP-1 cells (Jin et al, 2003). In previous reports, we showed that Cdk2 but not Cdc2 is selectively up-regulated and this upregulation is required for the induction of apoptosis in several cancer cell lines, including SK-HEP-1 cells and HeLa cells induced by treatment with ginsenoside-Rh2 (G-Rh2) (Jin et al, 2000) or panaxadiol (Jin et al, 2003).…”